Brachytherapy Market Size - Global Industry, Share, Analysis, Trends and Forecast 2024 - 2032
CHAPTER 1. Industry Overview of Brachytherapy Market
1.1. Definition and Scope
1.1.1. Definition of Brachytherapy
1.1.2. Market Segmentation
1.1.3. Years Considered for the Study
1.1.4. Assumptions and Acronyms Used
1.1.4.1. Market Assumptions and Market Forecast
1.1.4.2. Acronyms Used in Global Brachytherapy Market
1.2. Summary
1.2.1. Executive Summary
1.2.2. Brachytherapy Market By Dosage Type
1.2.3. Brachytherapy Market By Product
1.2.4. Brachytherapy Market By Application
1.2.5. Brachytherapy Market By Region
CHAPTER 2. Research Approach
2.1. Methodology
2.1.1. Research Programs
2.1.2. Market Size Estimation
2.1.3. Market Breakdown and Data Triangulation
2.2. Data Source
2.2.1. Secondary Sources
2.2.2. Primary Sources
CHAPTER 3. Market Dynamics And Competition Analysis
3.1. Market Drivers
3.1.1. Driver 1
3.1.2. Driver 2
3.1.3. Driver 3
3.2. Restraints and Challenges
3.2.1. Restraint 1
3.2.2. Restraint 2
3.2.3. Restraint 3
3.3. Growth Opportunities
3.3.1. Opportunity 1
3.3.2. Opportunity 2
3.3.3. Opportunity 3
3.4. Porter’s Five Forces Analysis
3.4.1. Bargaining Power of Suppliers
3.4.2. Bargaining Power of Buyers
3.4.3. Threat of Substitute
3.4.4. Threat of New Entrants
3.4.5. Degree of Competition
3.5. Market Concentration Ratio and Market Maturity Analysis of Brachytherapy Market
3.5.1. Go To Market Strategy
3.5.1.1. Introduction
3.5.1.2. Growth
3.5.1.3. Maturity
3.5.1.4. Saturation
3.5.1.5. Possible Development
3.6. Technological Roadmap for Brachytherapy Market
3.7. Value Chain Analysis
3.7.1. List of Key Manufacturers
3.7.2. List of Customers
3.7.3. Level of Integration
3.8. Cost Structure Analysis
3.8.1. Price Trend of Key Raw Materials
3.8.2. Raw Material Suppliers
3.8.3. Proportion of Manufacturing Cost Structure
3.8.3.1. Raw Material
3.8.3.2. Labor Cost
3.8.3.3. Manufacturing Expense
3.9. Regulatory Compliance
3.10. Competitive Landscape, 2023
3.10.1. Player Positioning Analysis
3.10.2. Key Strategies Adopted By Leading Players
CHAPTER 4. Manufacturing Plant Analysis
4.1. Manufacturing Plant Location and Establish Date of Major Manufacturers in 2023
4.2. R&D Status of Major Manufacturers in 2023
CHAPTER 5. Brachytherapy Market By Dosage Type
5.1. Introduction
5.2. Brachytherapy Revenue By Dosage Type
5.2.1. Brachytherapy Revenue (USD Million) and Forecast, By Dosage Type, 2020-2032
5.2.2. High-Dose Rate (HDR) Brachytherapy
5.2.2.1. High-Dose Rate (HDR) Brachytherapy Market Revenue (USD Million) and Growth Rate (%), 2020-2032
5.2.3. Low-Dose Rate (LDR) Brachytherapy
5.2.3.1. Low-Dose Rate (LDR) Brachytherapy Market Revenue (USD Million) and Growth Rate (%), 2020-2032
CHAPTER 6. Brachytherapy Market By Product
6.1. Introduction
6.2. Brachytherapy Revenue By Product
6.2.1. Brachytherapy Revenue (USD Million) and Forecast, By Product, 2020-2032
6.2.2. Seeds
6.2.2.1. Seeds Market Revenue (USD Million) and Growth Rate (%), 2020-2032
6.2.3. Applicators & Afterloaders
6.2.3.1. Applicators & Afterloaders Market Revenue (USD Million) and Growth Rate (%), 2020-2032
6.2.4. Electronic Brachytherapy
6.2.4.1. Electronic Brachytherapy Market Revenue (USD Million) and Growth Rate (%), 2020-2032
CHAPTER 7. Brachytherapy Market By Application
7.1. Introduction
7.2. Brachytherapy Revenue By Application
7.2.1. Brachytherapy Revenue (USD Million) and Forecast, By Application, 2020-2032
7.2.2. Prostate Cancer
7.2.2.1. Prostate Cancer Market Revenue (USD Million) and Growth Rate (%), 2020-2032
7.2.3. Gynaecological Cancer
7.2.3.1. Gynaecological Cancer Market Revenue (USD Million) and Growth Rate (%), 2020-2032
7.2.4. Breast Cancer
7.2.4.1. Breast Cancer Market Revenue (USD Million) and Growth Rate (%), 2020-2032
7.2.5. Others
7.2.5.1. Others Market Revenue (USD Million) and Growth Rate (%), 2020-2032
CHAPTER 8. North America Brachytherapy Market By Country
8.1. North America Brachytherapy Market Overview
8.2. U.S.
8.2.1. U.S. Brachytherapy Revenue (USD Million) and Forecast By Dosage Type, 2020-2032
8.2.2. U.S. Brachytherapy Revenue (USD Million) and Forecast By Product, 2020-2032
8.2.3. U.S. Brachytherapy Revenue (USD Million) and Forecast By Application, 2020-2032
8.3. Canada
8.3.1. Canada Brachytherapy Revenue (USD Million) and Forecast By Dosage Type, 2020-2032
8.3.2. Canada Brachytherapy Revenue (USD Million) and Forecast By Product, 2020-2032
8.3.3. Canada Brachytherapy Revenue (USD Million) and Forecast By Application, 2020-2032
8.4. North America PEST Analysis
CHAPTER 9. Europe Brachytherapy Market By Country
9.1. Europe Brachytherapy Market Overview
9.2. U.K.
9.2.1. U.K. Brachytherapy Revenue (USD Million) and Forecast By Dosage Type, 2020-2032
9.2.2. U.K. Brachytherapy Revenue (USD Million) and Forecast By Product, 2020-2032
9.2.3. U.K. Brachytherapy Revenue (USD Million) and Forecast By Application, 2020-2032
9.3. Germany
9.3.1. Germany Brachytherapy Revenue (USD Million) and Forecast By Dosage Type, 2020-2032
9.3.2. Germany Brachytherapy Revenue (USD Million) and Forecast By Product, 2020-2032
9.3.3. Germany Brachytherapy Revenue (USD Million) and Forecast By Application, 2020-2032
9.4. France
9.4.1. France Brachytherapy Revenue (USD Million) and Forecast By Dosage Type, 2020-2032
9.4.2. France Brachytherapy Revenue (USD Million) and Forecast By Product, 2020-2032
9.4.3. France Brachytherapy Revenue (USD Million) and Forecast By Application, 2020-2032
9.5. Spain
9.5.1. Spain Brachytherapy Revenue (USD Million) and Forecast By Dosage Type, 2020-2032
9.5.2. Spain Brachytherapy Revenue (USD Million) and Forecast By Product, 2020-2032
9.5.3. Spain Brachytherapy Revenue (USD Million) and Forecast By Application, 2020-2032
9.6. Rest of Europe
9.6.1. Rest of Europe Brachytherapy Revenue (USD Million) and Forecast By Dosage Type, 2020-2032
9.6.2. Rest of Europe Brachytherapy Revenue (USD Million) and Forecast By Product, 2020-2032
9.6.3. Rest of Europe Brachytherapy Revenue (USD Million) and Forecast By Application, 2020-2032
9.7. Europe PEST Analysis
CHAPTER 10. Asia Pacific Brachytherapy Market By Country
10.1. Asia Pacific Brachytherapy Market Overview
10.2. China
10.2.1. China Brachytherapy Revenue (USD Million) and Forecast By Dosage Type, 2020-2032
10.2.2. China Brachytherapy Revenue (USD Million) and Forecast By Product, 2020-2032
10.2.3. China Brachytherapy Revenue (USD Million) and Forecast By Application, 2020-2032
10.3. Japan
10.3.1. Japan Brachytherapy Revenue (USD Million) and Forecast By Dosage Type, 2020-2032
10.3.2. Japan Brachytherapy Revenue (USD Million) and Forecast By Product, 2020-2032
10.3.3. Japan Brachytherapy Revenue (USD Million) and Forecast By Application, 2020-2032
10.4. India
10.4.1. India Brachytherapy Revenue (USD Million) and Forecast By Dosage Type, 2020-2032
10.4.2. India Brachytherapy Revenue (USD Million) and Forecast By Product, 2020-2032
10.4.3. India Brachytherapy Revenue (USD Million) and Forecast By Application, 2020-2032
10.5. Australia
10.5.1. Australia Brachytherapy Revenue (USD Million) and Forecast By Dosage Type, 2020-2032
10.5.2. Australia Brachytherapy Revenue (USD Million) and Forecast By Product, 2020-2032
10.5.3. Australia Brachytherapy Revenue (USD Million) and Forecast By Application, 2020-2032
10.6. South Korea
10.6.1. South Korea Brachytherapy Revenue (USD Million) and Forecast By Dosage Type, 2020-2032
10.6.2. South Korea Brachytherapy Revenue (USD Million) and Forecast By Product, 2020-2032
10.6.3. South Korea Brachytherapy Revenue (USD Million) and Forecast By Application, 2020-2032
10.7. Rest of Asia-Pacific
10.7.1. Rest of Asia-Pacific Brachytherapy Revenue (USD Million) and Forecast By Dosage Type, 2020-2032
10.7.2. Rest of Asia-Pacific Brachytherapy Revenue (USD Million) and Forecast By Product, 2020-2032
10.7.3. Rest of Asia-Pacific Brachytherapy Revenue (USD Million) and Forecast By Application, 2020-2032
10.8. Asia Pacific PEST Analysis
CHAPTER 11. Latin America Brachytherapy Market By Country
11.1. Latin America Brachytherapy Market Overview
11.2. Brazil
11.2.1. Brazil Brachytherapy Revenue (USD Million) and Forecast By Dosage Type, 2020-2032
11.2.2. Brazil Brachytherapy Revenue (USD Million) and Forecast By Product, 2020-2032
11.2.3. Brazil Brachytherapy Revenue (USD Million) and Forecast By Application, 2020-2032
11.3. Mexico
11.3.1. Mexico Brachytherapy Revenue (USD Million) and Forecast By Dosage Type, 2020-2032
11.3.2. Mexico Brachytherapy Revenue (USD Million) and Forecast By Product, 2020-2032
11.3.3. Mexico Brachytherapy Revenue (USD Million) and Forecast By Application, 2020-2032
11.4. Rest of Latin America
11.4.1. Rest of Latin America Brachytherapy Revenue (USD Million) and Forecast By Dosage Type, 2020-2032
11.4.2. Rest of Latin America Brachytherapy Revenue (USD Million) and Forecast By Product, 2020-2032
11.4.3. Rest of Latin America Brachytherapy Revenue (USD Million) and Forecast By Application, 2020-2032
11.5. Latin America PEST Analysis
CHAPTER 12. Middle East & Africa Brachytherapy Market By Country
12.1. Middle East & Africa Brachytherapy Market Overview
12.2. GCC
12.2.1. GCC Brachytherapy Revenue (USD Million) and Forecast By Dosage Type, 2020-2032
12.2.2. GCC Brachytherapy Revenue (USD Million) and Forecast By Product, 2020-2032
12.2.3. GCC Brachytherapy Revenue (USD Million) and Forecast By Application, 2020-2032
12.3. South Africa
12.3.1. South Africa Brachytherapy Revenue (USD Million) and Forecast By Dosage Type, 2020-2032
12.3.2. South Africa Brachytherapy Revenue (USD Million) and Forecast By Product, 2020-2032
12.3.3. South Africa Brachytherapy Revenue (USD Million) and Forecast By Application, 2020-2032
12.4. Rest of Middle East & Africa
12.4.1. Rest of Middle East & Africa Brachytherapy Revenue (USD Million) and Forecast By Dosage Type, 2020-2032
12.4.2. Rest of Middle East & Africa Brachytherapy Revenue (USD Million) and Forecast By Product, 2020-2032
12.4.3. Rest of Middle East & Africa Brachytherapy Revenue (USD Million) and Forecast By Application, 2020-2032
12.5. Middle East & Africa PEST Analysis
CHAPTER 13. Player Analysis Of Brachytherapy Market
13.1. Brachytherapy Market Company Share Analysis
13.2. Competition Matrix
13.2.1. Competitive Benchmarking of key players by price, presence, market share, and R&D investment
13.2.2. New Product Launches and Product Enhancements
13.2.3. Mergers And Acquisition In Global Brachytherapy Market
13.2.4. Partnership, Joint Ventures and Strategic Alliances/ Sales Agreements
CHAPTER 14. Company Profile
14.1. Theragenics Corporation
14.1.1. Company Snapshot
14.1.2. Business Overview
14.1.3. Financial Overview
14.1.3.1. Revenue (USD Million), 2023
14.1.3.2. Theragenics Corporation, 2023 Brachytherapy Business Regional Distribution
14.1.4. Product /Service and Specification
14.1.5. Recent Developments & Business Strategy
14.2. Varian Medical Systems, Inc.
14.3. Eckert & Ziegler BEBIG
14.4. Becton, Dickinson and Company
14.5. iCAD, Inc.
14.6. Elekta AB
14.7. Isoray Medical, Inc.
14.8. CIVCO Medical Solutions
14.9. IsoAid LLC
14.10. Nanobiotix SA
Frequently Asked Questions
How big is the brachytherapy market?
The brachytherapy market size was valued at USD 912.5 million in 2023.
What is the CAGR of the global brachytherapy market from 2024 to 2032?
The CAGR of brachytherapy is 7.8% during the analysis period of 2024 to 2032.
Which are the key players in the brachytherapy market?
The key players operating in the global market are including Theragenics Corporation, Varian Medical Systems, Inc., Eckert & Ziegler BEBIG, Becton, Dickinson and Company, iCAD, Inc., Elekta AB, Isoray Medical, Inc., IsoAid LLC, Nanobiotix SA, and CIVCO Medical Solutions.
Which region dominated the global brachytherapy market share?
North America held the dominating position in brachytherapy industry during the analysis period of 2024 to 2032.
Which region registered fastest CAGR from 2024 to 2032?
Asia-Pacific region exhibited fastest growing CAGR for market of brachytherapy during the analysis period of 2024 to 2032.
What are the current trends and dynamics in the global brachytherapy industry?
The current trends and dynamics in the brachytherapy industry include increasing prevalence of cancer, particularly prostate and breast cancer, technological advancements improving treatment precision and outcomes, and growing adoption of outpatient procedures and personalized medicine.
Which dosage type held the maximum share in 2023?
The high-dose rate (HDR) brachytherapy dosage type held the maximum share of the brachytherapy industry.
Select Licence Type
Connect with our sales team
Why Acumen Research And Consulting
100%
Customer Satisfaction
24x7
Availability - we are always there when you need us
200+
Fortune 50 Companies trust Acumen Research and Consulting
80%
of our reports are exclusive and first in the industry
100%
more data and analysis
1000+
reports published till date
